Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00604
|
|||||
| Drug Name |
Cephalothin
|
|||||
| Synonyms |
Cephalothin; Cephalothin Sodium; Cephalothin Sodium W/ Dextrose In Plastic Container; Cephalothin Sodium W/ Sodium Chloride In Plastic Container; Keflin; Keflin In Plastic Container; Seffin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Bacterial infections [ICD11: 1A00-1H0Z] | Approved | [1] | |||
| Therapeutic Class |
Antiinfective Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H15N2NaO6S2
|
|||||
| Canonical SMILES |
CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]
|
|||||
| InChI |
InChI=1S/C16H16N2O6S2.Na/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10;/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23);/q;+1/p-1/t12-,15-;/m1./s1
|
|||||
| InChIKey |
VUFGUVLLDPOSBC-XRZFDKQNSA-M
|
|||||
| CAS Number |
CAS 58-71-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 418.4 | Topological Polar Surface Area | 169 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:3542
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | Cephalothin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). Biochem J. 2005 Jan 15;385(Pt 2):419-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.